04:35 PM EST, 12/22/2025 (MT Newswires) -- Amneal Pharmaceuticals ( AMRX ) and partner mAbxience said late Monday that the US Food and Drug Administration has approved their denosumab biosimilars, Boncresa and Oziltus. Boncresa is a biosimilar referencing Prolia, and Oziltus is a biosimilar referencing XGEVA, they said. Under the partnership, mAbxience develops and manufactures the drugs, while Amneal holds...

SINGAPORE--(BUSINESS WIRE)-- With reference to the stock exchange announcement of 18 December 2025, in which Hafnia Limited ( HAFN ) announced that all conditions precedent for completion of the share purchase agreement (the “Share Purchase Agreement”) entered into with Oaktree Capital Management, L.P. and its affiliates (together, Oaktree), have been satisfied, Hafnia ( HAFN ) is pleased to announce that...

04:36 PM EST, 12/22/2025 (MT Newswires) -- Integra Resources ( ITRG ) was at last look up 2% in US after hours trade Monday, while it has also touched a fresh 52 week high, as it announced the full conversion and repayment of the Beedie Investment convertible debenture facility. The company said it issued nearly 12.3 million common shares at...

04:36 PM EST, 12/22/2025 (MT Newswires) -- Neurocrine Biosciences ( NBIX ) said Monday its phase 3 trial assessing the efficacy, safety, and tolerability of valbenazine in pediatric and adult participants with dyskinetic cerebral palsy did not meet primary or key secondary endpoints. The primary goal of the trial was to evaluate improvement in chorea, which is a type of...